This is the authors' abstract. We don't add key points for this paper.
Background: Thymoma, commonly seen in middle-aged and elderly individuals, is associated with autoimmune disorders. While renal involvement is rare, its occurrence remains poorly characterized. Case Presentation: We report a 24-year-old female with a ten-year history of malignant thymoma who developed nephrotic syndrome. Renal biopsy revealed minimal change disease (MCD), a rare paraneoplastic manifestation of thymoma. Despite treatment with steroids and rituximab, her renal function deteriorated, leading to end-stage renal disease (ESRD). This case underscores the challenges of managing paraneoplastic glomerular disease and highlights the need for better understanding of such rare associations. Conclusion: Thymoma-related glomerular diseases, often linked to immune dysregulation, pose significant treatment challenges. Recognizing these associations may guide more effective management strategies, particularly for patients unresponsive to steroids.
No takes yet. Share an insight, caveat, or question.
James et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: